Diseases & Programmes
Developing World Health plans to develop two pharmaceutical products that it has already identified as highly promising treatments against four significant and devastating Neglected Tropical Diseases (NTDs). These products require additional clinical development in order to obtain medical approval for use in countries where they are urgently needed.
The four major NTDs being initially targeted by Developing World Health are:
- Leishmaniasis (Kala-azar)
- African Trypanosomiasis (sleeping sickness)
- Chagas Disease (American trypansomiasis)
- Dengue Fever (breakbone fever)
These four diseases alone affect some 3.2 million people each year and account for the deaths of approximately 150,000 people, many of them children.
Malaria, a global nemesis:
In addition to the neglected tropical diseases mentioned, Developing World Health is also developing a novel anti-malarial drug that, the Foundation believes, could be a major addition to the limited medication available to treat malaria.